Candriam SCA’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
Candriam SCA's TTPH Position: Q3 2019 in Review
Candriam SCA sold out of Tetraphase Pharmaceuticals (TTPH) in Q3 2019, closing a stake of 781 shares — an estimated $7K sold.
Candriam SCA first reported a position in TTPH in Q4 2014 and held it in 19 quarters. The position peaked at $6.78M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.
- Candriam SCA reported no remaining Tetraphase Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
- Candriam SCA sold 781 Tetraphase Pharmaceuticals shares in Q3 2019, an estimated $7K.
- Candriam SCA first reported a position in Tetraphase Pharmaceuticals in Q4 2014 and held it in 19 quarters.
- Candriam SCA's Tetraphase Pharmaceuticals position peaked at $6.78M in Q2 2015.
- 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q3 2019.
Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.